Literature DB >> 26131130

Cholangiocarcinoma: prognostic factors after surgical resection in China.

Yue Wang1, Helen Yang2, Chunjian Shen3, Ji Luo4.   

Abstract

OBJECTIVE: The management of cholangiocarcinoma remains a challenge due to poor prognosis. The aim of this study was to identify the influencing factors related to outcome of patients with cholangiocarcinoma.
METHODS: From January 1999 to January 2009, 169 cases of cholangiocarcinoma undergoing surgery were analyzed retrospectively. Relationships between survival and clinicopathological factors including patient demographics and tumor characteristics were evaluated using univariate and multivariate analysis.
RESULTS: The 1-, 3- and 5-year survival rates of patients after resection were 52.6%, 32.4%, 11.7%, respectively. Univariate analysis showed that CEA, lymph node metastasis, surgical margin, AJCC staging, tumor differentiation and adjuvant chemotherapy were prognostic impacts. The difference was statistically significant (P<0.05). Cox multivariate analysis showed that CEA, lymph node metastasis and surgical margin are three independent prognostic factors.
CONCLUSION: Radical resection is the key to improve the long-term survival rate of cholangiocarcinoma. Important predictive factors related to poor survival are CEA, lymph node metastasis and surgical margin.

Entities:  

Keywords:  Cholangiocarcinoma; prognosis; survival

Year:  2015        PMID: 26131130      PMCID: PMC4483825     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.

Authors:  Michael F Gerhards; Thomas M van Gulik; Dioniso González González; Erik A J Rauws; Dirk J Gouma
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

2.  Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

3.  Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hiroki Ohge; Taijiro Sueda
Journal:  Ann Surg Oncol       Date:  2010-10-14       Impact factor: 5.344

4.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

5.  Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroyuki Nakamura; Akira Nakashima; Taijiro Sueda
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

6.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroaki Nakamura; Akira Nakashima; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2009-05-07       Impact factor: 3.452

8.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

9.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

Review 10.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

View more
  4 in total

1.  Fyn knockdown inhibits migration and invasion in cholangiocarcinoma through the activated AMPK/mTOR signaling pathway.

Authors:  Shao-Cheng Lyu; Dong-Dong Han; Xian-Liang Li; Jun Ma; Qiao Wu; Hong-Meng Dong; Chun Bai; Qiang He
Journal:  Oncol Lett       Date:  2017-12-07       Impact factor: 2.967

2.  CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.

Authors:  Sven H Loosen; Christoph Roderburg; Katja L Kauertz; Alexander Koch; Mihael Vucur; Anne T Schneider; Marcel Binnebösel; Tom F Ulmer; Georg Lurje; Wenzel Schoening; Frank Tacke; Christian Trautwein; Thomas Longerich; Cornelis H Dejong; Ulf P Neumann; Tom Luedde
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

3.  Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.

Authors:  Yu Akazawa; Shoichi Mizuno; Norihiro Fujinami; Toshihiro Suzuki; Yusuke Yoshioka; Takahiro Ochiya; Yasunari Nakamoto; Tetsuya Nakatsura
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

4.  Fascin Induces Epithelial-Mesenchymal Transition of Cholangiocarcinoma Cells by Regulating Wnt/β-Catenin Signaling.

Authors:  Xianhai Mao; Xiaohui Duan; Bo Jiang
Journal:  Med Sci Monit       Date:  2016-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.